[Vinblastine + Procarbazine + Cyclophosphamide Association in the Treatment of Hodgkin's Disease (author's Transl)]

Overview

Journal Z Krebsforsch Klin Onkol Cancer Res Clin Oncol

Specialty Oncology

Date 1973 Nov 1

PMID 4271955

Citations 1

Authors

J Chauvergne

B Hoerni

G Hoerni-Simon

M Durand

C Lagarde

Affiliations

Soon will be listed here.

Citing Articles

Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Lagarde P, Bonichon F, Eghbali H, de Mascarel I, Chauvergne J, Hoerni B Br J Cancer. 1989; 59(4):645-9.

PMID: 2713252 PMC: 2247159. DOI: 10.1038/bjc.1989.131.

References

AMIEL J, Schlienger M, Laugier A, Rouesse J, Jasmin C, Hayat M . [Therapeutic trial in disseminated Hodgkin's disease (stages 3 and IV) by sequence chemotherapy, radiotherapy, eventually associated with splenectomy and supplementary chemotherapy]. Nouv Rev Fr Hematol. 1970; 10(5):597-608. View

JACQUILLAT C, Weil M, DESPREZ-CURELY J, Tanzer J, Gemon M, Blouin R . [Chemotherapy of Hodgkin's disease with therapeutic associations]. Bull Cancer. 1971; 58(2):221-34. View

. A randomized study of irradiation and vinblastine in stages I and II of Hodgkin's disease. Preliminary results. Eur J Cancer (1965). 1972; 8(3):353-62. DOI: 10.1016/0014-2964(72)90032-1. View

Chauvergne J, Hoerni B . [Proposal for standardization of the appraisal of therapeutical results]. Bord Med. 1971; 4(5):1513-4. View